Dr. Perry Calias brings over 25 years of biopharmaceutical experience in clinical development across the drug and device sectors of healthcare. His strengths include pre-clinical, clinical development, CMC and global regulatory submissions. Dr. Calias has extensive experience in CNS and neurology, as well as rare diseases. He has a strong track record in compound development, drug delivery and pipeline progression, as well as building research and development organizations. He is listed as an inventor on over 30 domestic and foreign patents/applications spanning 18 different patent families. His previous experience includes serving as Chief Scientific Officer and Head of R&D at Cerecor and Vice President of Global CMC and Product Development at Sucampo. He has held a variety of research and development positions both in clinical and non-clinical roles of expanded leadership at Shire HGT and Genzyme. Dr. Calias has a strong background in early stage asset development as well as clinical trial experience. Dr. Calias obtained his Ph.D. in Bio-Organic hemistry from Tufts University and his B.S. in Biology from Suffolk University.